NRG1 fusions are enriched in aggressive mucinous adenocarcinoma of the lung, but have a low incidence in multiple tumor types (Nakaoku et al., 2014; Jones et al., 2017; Heining et al., 2018; Trombetta et al., 2018). Here, NRG1 is linked to neoplasm.